Valuation (83%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 6.58 | 17.70 |
| PEG Ratio (TTM) | 0.28 | 2.25 |
| P/S Ratio (TTM) | 1.49 | 1.60 |
| P/B Ratio (TTM) | 2.25 | 3.09 |
| P/FCF Ratio (TTM) | 2.82 | 7.45 |
| Price to 5YR AVG Earnings Ratio | 43.96 | 18.71 |
| Price to 5YR AVG FCF Ratio | 12.20 | 11.78 |
Profitability (65%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 10.30% | 3.97% |
| ROE (TTM) | 44.73% | 15.45% |
| Net Profit Margin (TTM) | 21.63% | 9.35% |
| ROIC 5YR AVG | -1,999.96% | 8.48% |
Growth (67%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 51.62% | -6.82% | -113.69% |
| Revenue | 13.45% | 22.23% | 19.87% |
| Net Income | 58.46% | -6.68% | -125.85% |
| Cash Flow | 48.87% | 52.29% | 389,683.04% |
Health (77%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.59 | 0.76 |
| Quick Ratio (TTM) | 6.13 | 1.89 |
| D/E Ratio (TTM) | 0.41 | 0.35 |
| Interest Coverage (TTM) | 30.23 | 15.49 |
| Piotroski F-Score | 8 | 7 |
| Altman Z-Score | 2.30 | 1.44 |
| LTL to 5YR AVG FCF | 2.42 | 1.39 |
| Shares Outstanding Growth 5YR AVG | 1.39% | -1.61% |